Premium
Allergic contact dermatitis caused by transdermal buprenorphine
Author(s) -
Kyrklund Carl,
Hyry Heli,
Alanko Kristiina
Publication year - 2013
Publication title -
contact dermatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.524
H-Index - 96
eISSN - 1600-0536
pISSN - 0105-1873
DOI - 10.1111/cod.12051
Subject(s) - medicine , allergy , dermatology , allergic contact dermatitis , university hospital , drug allergy , atopic dermatitis , surgery , immunology
Buprenorphine is a potent semisynthetic opioid analgesic that is widely used to treat moderate to severe pain. Since 2001, it has been available in several European countries in a transdermal delivery system (TDS), and it was approved for use in the United States in 2010. We report 3 cases of allergic contact dermatitis caused by a TDS containing buprenorphine, as verified by a positive patch test reaction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom